DHA omega-3 is estimated to lead ingredient demand with 40.0% share in 2026, with powder representing 45.2% by form and fish representing 63.1% by source. Commercial adoption depends on reliable dosing and stable processing across maternal products under country-specific permissions and tolerability limits.